Tennessee Oncology 250 20th Ave North — Nashville, Tennessee

Tennessee Oncology 250 20th Ave North is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Tennessee Oncology 250 20th Ave North has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology 250 20th Ave North?

Tennessee Oncology 250 20th Ave North has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology 250 20th Ave North conducted?

Tennessee Oncology 250 20th Ave North has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is Tennessee Oncology 250 20th Ave North accredited by Crixeo Health?

Tennessee Oncology 250 20th Ave North has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology 250 20th Ave North?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.